Has NEU applied to FDA for IND in relation to the new indications. They have had enough time to submit the animal studies and other preclinical data to the FDA.
It would certainly be exciting to have these indications released with FDA approvals to go into a PH2 trials .
From memory the first 4 indications came with the FDA IND announcement and start of ph1 trials.
Think the first Ph1 trials should cover off the safety and toxicity profile of 2591.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.31 |
Change
0.770(6.14%) |
Mkt cap ! $1.655B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $19.76M | 1.453M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3000 | $13.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.33 | 3716 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |